Rights and permissions
About this article
Cite this article
Rosiglitazone and MI risk - will we ever know the answer?. Inpharma Wkly. 1594, 3 (2007). https://doi.org/10.2165/00128413-200715940-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715940-00003